Answers are grounded in this paper and cite their sources.
OBJECTIVES: To examine the activity of ceftaroline against reduced-vancomycin-susceptible MRSA isolates. METHODS: One-hundred and three MRSA blood culture isolates (predominantly ST239-MRSA-III), with varying vancomycin phenotypes, had their ceftaroline MICs determined by broth microdilution and MIC Evaluator strip (Oxoid-Thermo Fisher). Statistical analyses were performed that examined relationships with vancomycin and daptomycin MICs. Mutations in mecA were also examined. RESULTS: All 103 isolates (including 60 heteroresistant vancomycin-intermediate Staphylococcus aureus/vancomycin-intermediate S. aureus) were susceptible to ceftaroline, with one isolate displaying heteroresistance that may be related to a mecA mutation. Higher ceftaroline MICs were associated with vancomycin-susceptible S. aureus isolates. CONCLUSIONS: This study highlights that ceftaroline fosamil is an option for salvage therapy based on in vitro activity.
No takes yet. Share an insight, caveat, or question.
Espedido et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: